BioNTech (BNTX) News Today $89.94 -0.21 (-0.23%) (As of 09/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period September 7 at 7:44 AM | marketbeat.comBioNTech SE (NASDAQ:BNTX) Shares Purchased by Candriam S.C.A.Candriam S.C.A. lifted its stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 261.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 578,998 shares of the company's stock after purchasing an additional 418,695 shaSeptember 6 at 5:21 PM | benzinga.comModerna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study ShowsSeptember 5 at 7:15 AM | globenewswire.comBioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024September 4 at 9:01 AM | finance.yahoo.comTempus Announces Real World Data Collaboration with BioNTechSeptember 4 at 9:01 AM | markets.businessinsider.comTempus AI Signs Real World Data Collaboration With BioNTech To Support Oncology PipelineSeptember 3, 2024 | markets.businessinsider.comMorgan Stanley Sticks to Its Hold Rating for BioNTech SE (BNTX)September 3, 2024 | msn.comUK, Taiwan Approve Moderna's Updated COVID-19 ShotSeptember 3, 2024 | marketwatch.comBioNTech SE ADR outperforms market despite losses on the daySeptember 3, 2024 | americanbankingnews.comAtara Biotherapeutics (NASDAQ:ATRA) versus BioNTech (NASDAQ:BNTX) Head to Head ComparisonSeptember 1, 2024 | marketbeat.comInvestmentaktiengesellschaft Fuer Langfristige Investoren TGV Has $1.65 Million Position in BioNTech SE (NASDAQ:BNTX)Investmentaktiengesellschaft Fuer Langfristige Investoren TGV raised its stake in BioNTech SE (NASDAQ:BNTX - Free Report) by 41.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,500 shares of the coAugust 30, 2024 | americanbankingnews.comQ3 2024 EPS Estimates for BioNTech SE Lifted by Analyst (NASDAQ:BNTX)August 29, 2024 | americanbankingnews.comFY2024 EPS Estimates for BioNTech SE (NASDAQ:BNTX) Reduced by HC WainwrightAugust 29, 2024 | marketbeat.comHC Wainwright Equities Analysts Reduce Earnings Estimates for BioNTech SE (NASDAQ:BNTX)BioNTech SE (NASDAQ:BNTX - Free Report) - Equities researchers at HC Wainwright reduced their FY2024 EPS estimates for shares of BioNTech in a research note issued on Tuesday, August 27th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings of ($3.71) per share for thAugust 28, 2024 | marketbeat.comQ3 2024 EPS Estimates for BioNTech SE Increased by HC Wainwright (NASDAQ:BNTX)BioNTech SE (NASDAQ:BNTX - Free Report) - Investment analysts at HC Wainwright lifted their Q3 2024 earnings estimates for BioNTech in a research report issued to clients and investors on Tuesday, August 27th. HC Wainwright analyst R. Burns now expects that the company will post earnings per sharAugust 28, 2024 | americanbankingnews.comBioNTech's (BNTX) Buy Rating Reaffirmed at HC WainwrightAugust 27, 2024 | finance.yahoo.comBioNTech initiates global trials of mRNA-based lung cancer vaccineAugust 27, 2024 | markets.businessinsider.comMorgan Stanley Keeps Their Hold Rating on BioNTech SE (BNTX)August 27, 2024 | markets.businessinsider.comBuy Rating for BioNTech SE: FDA Approval and Advancements in mRNA Vaccine PipelineAugust 27, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Given "Buy" Rating at HC WainwrightHC Wainwright restated a "buy" rating and set a $113.00 price objective on shares of BioNTech in a research note on Tuesday.August 26, 2024 | markets.businessinsider.comBioNTech Starts BNT116 Lung Cancer MRNA Vaccine Clinical TrialsAugust 25, 2024 | globenewswire.comBioNTech BNT116 Lung Cancer mRNA Vaccine Clinical Trials InitiatedAugust 23, 2024 | markets.businessinsider.comPfizer, BioNTech Obtain FDA Approval & Authorization For Omicron KP.2-adapted COVID-19 VaccineAugust 22, 2024 | businesswire.comPfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 VaccineAugust 22, 2024 | globenewswire.comPfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 VaccineAugust 21, 2024 | marketbeat.comResearch Analysts Offer Predictions for BioNTech SE's FY2024 Earnings (NASDAQ:BNTX)BioNTech SE (NASDAQ:BNTX - Free Report) - Research analysts at HC Wainwright decreased their FY2024 EPS estimates for BioNTech in a research report issued on Monday, August 19th. HC Wainwright analyst R. Burns now expects that the company will earn ($3.66) per share for the year, down from theirAugust 20, 2024 | seekingalpha.comBioNTech: Clinical Hold Removal Pushes ADC Development Program ForwardAugust 20, 2024 | marketbeat.comQ3 2024 Earnings Forecast for BioNTech SE (NASDAQ:BNTX) Issued By HC WainwrightBioNTech SE (NASDAQ:BNTX - Free Report) - HC Wainwright raised their Q3 2024 earnings per share estimates for BioNTech in a report released on Monday, August 19th. HC Wainwright analyst R. Burns now expects that the company will post earnings of $0.85 per share for the quarter, up from their prioAugust 19, 2024 | msn.comFDA Allows Resumption Of BioNTech/MediLink Therapeutics Partnered Phase 1 Study For Cancer Drug With Lower DoseAugust 19, 2024 | benzinga.comUnveiling 12 Analyst Insights On BioNTechAugust 19, 2024 | marketwatch.comBioNTech SE ADR rises Monday, outperforms marketAugust 19, 2024 | marketbeat.comModerna Dips on Q2 Earnings But Can It Rip on a Short Squeeze? (BNTX)Biotechnology company Moderna Inc. (NASDAQ: MRNA) stock rocked investors with a 30% drop following its second-quarter 2024 earnings release.August 19, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $113.00 price target on shares of BioNTech in a research note on Monday.August 19, 2024 | fool.comPfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?August 18, 2024 | markets.businessinsider.comBuy Rating Affirmed for BioNTech Amidst Flu/COVID Vaccine Potential and Strong Oncology PipelineAugust 16, 2024 | finance.yahoo.comPfizer and BioNTech’s Covid-19/flu combination vaccine falters in Phase III readoutAugust 16, 2024 | marketwatch.comBioNTech SE ADR falls Friday, underperforms marketAugust 16, 2024 | finance.yahoo.comPfizer, BioNTech stumble in effort to develop combination flu, COVID shotAugust 16, 2024 | msn.comPfizer, BioNTech Covid-Flu Combination Shot Misses on Trial GoalAugust 16, 2024 | markets.businessinsider.comPfizer, BioNTech Announce Top-line Results In Phase 3 Trial Of MRNA-based Combination VaccineAugust 16, 2024 | msn.comPfizer, BioNTech post partial win in late-stage trial for COVID/flu combo shotAugust 16, 2024 | investopedia.comPfizer, BioNTech Combination Flu and COVID-19 Shot Misses 1 of 2 EndpointsAugust 16, 2024 | ft.comBioNTech/Pfizer Covid and flu combo vaccine falters in late-stage trialAugust 16, 2024 | reuters.comPfizer, BioNtech say combined flu-COVID vaccine misses a main goal of Phase 3 trialAugust 16, 2024 | globenewswire.comPfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of AgeAugust 12, 2024 | marketbeat.comNovavax Plunges on Earnings Miss: Falling Knife or Buying Opp? (BNTX)Novavax Inc. (NASDAQ: NVAX) is a biotechnology company that focuses on developing and commercializing vaccines for serious infectious diseases.August 12, 2024 | marketbeat.comSG Americas Securities LLC Has $4.83 Million Position in BioNTech SE (NASDAQ:BNTX)SG Americas Securities LLC trimmed its position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 14.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 60,062 shares of the company's stock afterAugust 9, 2024 | marketwatch.comBioNTech SE ADR rises Friday, still underperforms marketAugust 9, 2024 | marketwatch.comBioNTech SE ADR rises Thursday, still underperforms marketAugust 7, 2024 | reuters.comBioNTech sued by UPenn over COVID-19 vaccine patent royaltiesAugust 7, 2024 | msn.comDeutsche Bank Upgrades BioNTech SE - Depositary Receipt () (BNTX) Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden’s Capital Gains Tax to Devastate Savings! (Ad)Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security. >> Get Your FREE Wealth Protection Guide << BNTX Media Mentions By Week BNTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼0.340.55▲Average Medical News Sentiment BNTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼109▲BNTX Articles Average Week Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Takeda Pharmaceutical News Today Moderna News Today Teva Pharmaceutical Industries News Today BeiGene News Today Genmab A/S News Today Viatris News Today Dr. Reddy's Laboratories News Today Sarepta Therapeutics News Today Catalent News Today Legend Biotech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free bntx Stock Alerts